News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A US FDA advisory committee has voted overwhelmingly in favour of licensing Celltrion and Pfizer’s version of J&J’s Remicade, paving the way for the first US monoclonal antibody biosimilar.
Cell Therapy Manufacturing & Gene Therapy Congress, Brussels
Reliance on third-party technologies is leaving T-Cell drug developers vulnerable and has driven the larger players to invest in their own platforms, say experts.
GSK will test a stability enhancement technology developed by VBI Vaccines in a deal announced this week.